Hypotensive treatment after stroke -- the MOSES study documented superiority of eprosartan over nitrendipine
Prejbisz, A.
Kardiologia Polska 63(6): 671
2005
ISSN/ISBN: 0022-9032 PMID: 16380877 Document Number: 591246
Document emailed within 1 workday
Related Documents
El-Yazbi, F.A.; Hammud, H.H.; Sonji, N.M.; Sonji, G.M. 2008: Spectral and polarographic determination of eprosartan. Kinetic studies of the oxidation of eprosartan using a platinum electrode Die Pharmazie 63(6): 420-427Martynov, M.Iu.; Boĭko, A.N.; Petukhov, E.B.; Berezov, V.P.; Maskarov, A.N.; Gusev, E.I. 2002: Eprosartan mesylate in controlling of blood pressure in patients with ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(4): 26-30
Heinzl, S. 2004: Stroke: which risk factors are scientifically documented? Medizinische Monatsschrift für Pharmazeuten 27(6): 181
Krause, H.P.; Ahr, H.J.; Siefert, H.M.; Steinke, W.; Suwelack, D. 1988: The pharmacokinetics of nitrendipine. II. Distribution to and elimination from organs and tissues of rats and dogs after single or repeated administration of [14C]nitrendipine Arzneimittel-Forschung 38(11): 1599-1604
Wiersma, T. 2002: Less chance of a stroke due to hypotensive medication, regardless of blood pressure Nederlands Tijdschrift Voor Geneeskunde 146(18): 874; Author Reply 874
2001: Controlled evaluation study of MOSES: effective and popular! MMW Fortschritte der Medizin 143(38): 55
Hanchaiphiboolkul, S.; Poungvarin, N.; Nidhinandana, S.; Suwanwela, N.C.; Puthkhao, P.; Towanabut, S.; Tantirittisak, T.; Suwantamee, J.; Samsen, M. 2011: Prevalence of stroke and stroke risk factors in Thailand: Thai Epidemiologic Stroke (TES) Study Journal of the Medical Association of Thailand 94(4): 427-436
Gallo, S.; Dibildox, M.; Moguel, A.; Di Silvio, M.; Rodríguez, F.; Almaguer, I.; García, C. 1998: Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade Ii and III. a prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group Revista de Gastroenterologia de Mexico 63(1): 11-16
Nalin, G.; Beghelli, G. 1996: Antihypertensive treatment with nitrendipine Minerva Cardioangiologica 44(1-2): 67-72
Perrone, A.; Corsi, C.; Familiari, G.; Contin, G.; Villani, R.D.; D'Amico, G.; Nava, A. 1983: Superiority of the Rives technic in the treatment of laparoceles Minerva Chirurgica 38(17): 1271-1278
Nechwatal, W. 1987: Doxazosin and nitrendipine. a double-blind comparative study in patients with mild to moderate hypertension Fortschritte der Medizin 105(34): 679-682
Uldall, P. 2015: The treatment of cerebral palsy is poorly documented Ugeskrift for Laeger 177(28)
Lopes, H.F.; Silva, H.B.; Bellotti, G.; Pillegi, F. 1990: Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension Arquivos Brasileiros de Cardiologia 54(3): 227-229
Müller, R.; Steffen, H.M.; Kugel, C.; Freiheit, T.; Franzen, D.; Wambach, G.; Kaufmann, W. 1991: Different changes in the adrenergic system with nitrendipine and captopril and different therapeutic aspects in treatment of hypertension and heart failure Zeitschrift für Kardiologie 80(Suppl 8): 109-110
Greene, J. 2015: Cancer competition. As local treatment centers grow, hospitals look for ways to advertise their superiority Modern Healthcare 45(46): 24-26
Adam, Z.; Szturz, P.; Křen, L.; Krejčí, M.; Pour, L.; Svoboda, T.; Hanke, I.; Penka, I.; Koukalová, R.; Rehák, Z.; Cervinková, I.; Storková, T.; Král, Z.; Mayer, J. 2013: PET-CT documented fast onset of treatment response to cyclophosphamide, thalidomide and dexamethasone in patients with multicentric Castlemans disease. Case description and treatment information overview Vnitrni Lekarstvi 59(4): 301-312
Wortzel, M.H. 1982: A double-blind study comparing the superiority of a combination antifungal (clotrimazole)/steroidal (betamethasone dipropionate) product Cutis 30(2): 258-261
Kostial, K.; Blanusa, M.; Piasek, M.; Simonović, I.; Jones, M.M.; Singh, P.K. 1993: Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats Arhiv Za Higijenu Rada i Toksikologiju 44(3): 217-222
Mancarella, L.; Battaglia, M.; Addimanda, O.; Pelotti, P.; Galletti, S.; Meliconi, R. 2010: Successful adalimumab treatment of HLA B27 negative heel enthesitis documented with MRi and US Clinical and Experimental Rheumatology 28(3): 443-444
Pipatvanichgul, B.; Hanchaiphiboolkul, S.; Puthkhao, P.; Tantirittisak, T.; Towanabut, S. 2015: Association between Socioeconomic Status and Major Risk Factors of Stroke: Thai Epidemiologic Stroke (TES) Study Journal of the Medical Association of Thailand 98(8): 739-747